Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Paul C. Langley, PhD

Advertisement

Articles by Paul C. Langley, PhD

Is Cost-Effectiveness Modeling Useful?

ByPaul C. Langley, PhD
February 1st 2000

The Cost Effectiveness of Patient-Applied Versus Provider-Administered Intervention Strategies for the Treatment of External Genital Warts

ByPaul C. Langley, PhD,Stephen K. Tyring, MD, PhD,Michael H. Smith, MS
January 1st 1999

Pharmacoeconomics Perspectives: Payers, Providers, and Patients

ByPaul C. Langley, PhD,Nicolaas Otten, PharmD,Peter Davey, MD,James C. Bonnette, MD,J. Russell Teagarden,William F. McGhan, PharmD, PhD
April 1st 1998

Managed Care Guidelines for the Economic Evaluation of Pharmaceuticals

ByPaul C. Langley, PhD,Robert E. Martin, MS, RPh
July 1st 1997

Establishing the Basis for Successful Disease Management Contracting

ByPaul C. Langley, PhD,Clare E. Langley-Hawthorne, LLB,Robert E. Martin, RPh, MS,Edward P. Armstrong, PharmD
September 1st 1996
Advertisement

Latest Updated Articles

  • Managed Care Guidelines for the Economic Evaluation of Pharmaceuticals
    Managed Care Guidelines for the Economic Evaluation of Pharmaceuticals

    July 1st 1997

  • The Cost Effectiveness of Patient-Applied Versus Provider-Administered Intervention Strategies for the Treatment of External Genital Warts
    The Cost Effectiveness of Patient-Applied Versus Provider-Administered Intervention Strategies for the Treatment of External Genital Warts

    January 1st 1999

  • Establishing the Basis for Successful Disease Management Contracting
    Establishing the Basis for Successful Disease Management Contracting

    September 1st 1996

  • Is Cost-Effectiveness Modeling Useful?
    Is Cost-Effectiveness Modeling Useful?

    February 1st 2000

  • Pharmacoeconomics Perspectives:  Payers, Providers, and Patients
    Pharmacoeconomics Perspectives: Payers, Providers, and Patients

    April 1st 1998



Advertisement
Advertisement

Trending on AJMC

1

FDA Panel Backs 6 Peptides for Compounding

2

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

3

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

4

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

5

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text